This continuing medical education program is designed to provide general practitioners with an up-to-date approach to the management of diabetes, with the aim of optimising outcomes for their patients. The program has an emphasis on the role of DPP4 inhibitors, and their place in the 2020 Australian Diabetes Society and RACGP type 2 diabetes management algorithm.
This program is supported by an independent educational grant provided by MSD.